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Introduction and context {#s01}
========================

With each breath exhaled thousands of molecules are expelled, providing a window into the physiological state of the body. The utilization of breath as a medical test has been reported for centuries as demonstrated by Hippocrates in his description of fetor oris and fetor hepaticus in his treatise on breath aroma and disease \[[@bib-001]\]. Even in modern times clinicians have noted distinct changes in the breath odor of patients with specific diseases such as diabetes, renal failure, and hepatic diseases \[[@bib-002]-[@bib-004]\]. However, it was Linus Pauling's milestone discovery of 250 unique substances present in exhaled breath that offered promising insight into breath testing \[[@bib-005]\]. Since this discovery, breath analysis has rapidly evolved as a new frontier in medical testing for disease states in the lung and beyond \[[@bib-001]\]. Breath analysis is now used clinically to monitor asthma, diagnose transplant organ rejection, diagnose *Helicobacter pylori* infection, detect blood alcohol concentration, and monitor breath gases during anesthesia, mechanical ventilation, and respiration, among numerous other applications \[[@bib-001],[@bib-006],[@bib-007]\].

Recent advances {#s02}
===============

Breath analysis may offer a relatively inexpensive, rapid, and non-invasive method for detecting a variety of diseases. With recent advancements in mass spectrometry (MS) and gas chromatography MS (GC-MS), it is possible to identify thousands of unique substances, such as volatile organic compounds (VOCs) and elemental gases, in the breath \[[@bib-008]\]. Improved technologies such as selected-ion flow-tube MS (SIFT-MS), multi-capillary column ion mobility MS (MCC-IMS), and proton transfer reaction MS (PTR-MS) have provided real time, precise identification of trace gases in human breath in the parts per trillion range \[[@bib-009]-[@bib-011]\]. On the other hand, unlike traditional quantitative breath analysis, the electronic nose is essentially trained to recognize odor patterns using an array of gas sensors. The electronic nose has shown accuracy in the detection of lung cancer, pneumonia, and asthma with specificities and sensitivities ranging from 74-98%, as well as in the discrimination between diseases such as chronic obstructive pulmonary disease and asthma \[[@bib-012]-[@bib-015]\]. [Table 1](#tbl-001){ref-type="table"} provides a selected list of the growing number of technologies being applied to breath testing.

###### Current breath-based test technologies
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  Spectrometry                                                                                  Gas chromatography                                                                              Other
  --------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------- ----------------------------------------
  Mid-infrared absorption spectroscopy                                                          Automated thermal desorption gas chromatography mass spectrometry (ATD-GC-MS)                   Chemiluminescense
  Multi pass cell-laser absorption spectroscopy                                                 Gas chromatography flame ionization detection (GC-FID)                                          Electrochemical cell sensor technology
  Tunable diode laser absorption spectroscopy (TDLAS)                                           Gas chromatrography mass spectrometry (GC-MS)                                                   Gas sensor array technology
  Cavity ring-down spectroscopy (CRDS)                                                          Photoionization detection gas chromatography                                                    Nanosensor technology
  Cavity leak-out spectroscopy (CALOS)                                                          Solid phase microextraction gas chromatography mass spectrometry (SPME-GC-MS)                   Infrared and para-magnetic sensors
  Cavity enhanced optical frequency comb spectroscopy                                           Gas chromatography time of flight mass spectrometry (GC-TOF-MS)                                 Calorimetry
  Integrated cavity output spectroscopy (ICOS)                                                  Gas chromatography differential mobility spectrometry (GC-DMS)                                  Sol-gel sensor technology
  Laser magnetic resonance spectroscopy (LMRS)                                                  Gas chromatography ion mobility mass spectrometry (GC-IMS-MS)                                   Laser based sensor technology
  Laser photoacoustic spectroscopy                                                              Gas chromatography/Fourier transform ion cyclotron resonance mass spectrometry (GC/FT-ICR-MS)   
  Faraday-LMRS                                                                                  Gas-liquid partition chromatography (GLPC)                                                      
  Selected ion flow tube mass spectrometry (SIFT-MS)                                            Gas chromatography electrolyzer-powered flame ionization detector (GC-EFID)                     
  Proton transfer reaction mass spectrometry (PTR-MS)                                                                                                                                           
  Faraday modulation spectroscopy                                                                                                                                                               
  Ion trap (2D) and (3D) mass spectrometry                                                                                                                                                      
  Time of flight mass spectrometry (TOF-MS)                                                                                                                                                     
  Isotope ratio mass spectrometry (IR-MS)                                                                                                                                                       
  Multi-capillary column ion mobility mass spectrometry (MCC-IMS)                                                                                                                               
  High sensitivity (hs)-PTR-MS                                                                                                                                                                  
  Matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS)                                                                                                   
  Proton transfer reaction time of flight mass spectrometry (PTR-TOF-MS)                                                                                                                        

More recent technological advancements in breath analysis have moved beyond measuring volatiles in the gas phase into measurement of semivolatiles and compounds dissolved in aerosolized droplets in exhaled breath condensate (EBC) and in exhaled breath vapor (EBV). Aerosolized droplets in EBC can be captured by a variety of methods and analyzed for a wide range of biomarkers, such as metabolic end products, proteins, cytokines, and chemokines, with expanding possibilities \[[@bib-016],[@bib-017]\]. With 3000 volatile compounds identifiable using EBC and twice the volatile metabolite concentration compared to traditional breath gas analysis, this application has the potential to provide superior information about breathprints of healthy and disease states \[[@bib-008],[@bib-018]\]. EBV sampling has also yielded promising results as a new breath sampling method. EBV sampling pre-concentrates breath samples using a solid-phase microextraction fiber inserted into a modified RTube™, a common device also used in EBC sampling. This procedure provides the potential advantages of faster breath sampling and analysis, increased portability, minimal user training, use in contaminated environments, and no requirement for a power source. EBV sampling may yield additional compounds not detected in EBC and may provide greater sensitivity as a sampling method, expanding the spectrum of breath sampling \[[@bib-019]\].

Implications for clinical practice {#s03}
==================================

The science of breath analysis is rapidly expanding, the technology is improving, and several new applications have been developed or are under commercial development. A major breakthrough over the past decade has been the increase in breath-based tests approved by the US Food and Drug Administration (FDA). Devices measuring common breath gases: oxygen, nitrogen, water vapor, and carbon dioxide in patient respiratory monitoring have served as a platform for technological growth in clinical breath testing applications. In particular, earlier devices, such as those providing the detection of blood alcohol concentration, *H. pylori* infection, lactose intolerance, and airway monitoring by end-tidal carbon dioxide, have demonstrated clinical benefits as well as diagnostic success in clinical breath testing. [Table 2](#tbl-002){ref-type="table"} provides a selected list of the breath-based tests currently approved by the FDA.

###### Breath-based tests approved by the US Food and Drug Administration \[[@bib-033]\]
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  Molecule detected                                 Disease/condition                    Trade name of analysis instrument                                Technology                                              Manufacturer                                                        FDA approval date
  ------------------------------------------------- ------------------------------------ ---------------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------------------- --------------------
  CO~2,~ O~2,~ N~2~O                                Respiration                          Consolidated-Nier model 21-201 isotope ratio mass spectrometer   Dual inlet system gas isotope ratio mass spectrometer   Consolidated Electrodynamics Corporation, Inc., Pasadena, CA, USA   Before 28 May 1976
  CO~2~                                             Respiration                          Tidal Wave^®^ Carbon Dioxide Monitor, Model 610                  Sensor technology                                       Novametrix Medical Systems, Inc., Wallingford, CT, USA              20 November 1996
  H~2~                                              Lactose malabsorption                Micro H2                                                         Sensor technology                                       MICRO DIRECT, Inc., Auburn, ME USA                                  24 January 1997
  ^13^C, ^18^O, CO~2~, ^15^N, N~2~, NO~2~           Respiration                          ABCA-NT System                                                   Continuous flow gas isotope ratio mass spectrometer     Europa Scientific, Ltd. Concord, MA USA                             16 December 1997
  CO~2,~ O~2,~ N~2~O and anesthetic agents          Respiration, anesthesia              Datex-Ohmeda Compact Airway Module M-CAiOVX and M-COVX           Infrared sensor, paramagnetic sensor                    Datex-Ohmeda, Inc., Tewksbury, MA, USA                              23 August 2000
  ^13^CO~2~/^12^CO~2~                               *H. pylori*                          UBiT^®^-IR3000 Infrared Spectrometry System                      Infrared (IR) spectrophotometer                         Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan                        21 December 2001
  O~2~, CO~2~                                       Respiration                          BSM-4100A                                                        Sensor technology                                       Nihon Kohden America Inc., Foothill Ranch, CA, USA                  24 October 2000
  ^13^CO~2~/^12^CO~2~                               *H. pylori*                          BreathTek™ - UBiT^®^ UBT for *Helicobacter pylori*               UBiT^®^ IR spectrophotometer                            Meretek Diagnostics, Inc., Nashville, TN, USA                       17 January 2002
  O~2~, CO~2~, N~2~O, anesthetic agents             Respiration, anesthesia              Ag-920PA                                                         Sensor technology                                       Nihon Kohden America Inc., Foothill Ranch, CA, USA                  25 July 2002
  O~2~, CO~2~, N~2~O, anesthetic agents and gases   Respiration, anesthesia              BSM-5130A Series Bedside Monitor                                 Sensor technology                                       Nihon Kohden America, Inc., Foothill Ranch, CA, USA                 March 04, 2003
  NO                                                Asthma, airway inflammation          NIOX^®^                                                          Chemiluminescence                                       Aerocrine AB, Solna, Sweden                                         30 April 2003
  CO~2~                                             Respiration, anesthesia              Datex-Ohmeda S/5 Single-Width Airway Module M-miniC              MiniCO2 IR measuring sensor                             Datex-Ohmeda, Needham, MA, USA                                      23 April 2003
  (C4-C20) alkanes, monomethylalkanes               Grade 3 heart transplant rejection   Heartsbreath                                                     Gas chromatography mass spectrometry                    Menssana Research, Inc., Fort Lee, NJ, USA                          24 February 2004
  H~2~                                              Lactose malabsorption                Micro H2 Breath Monitoring Device with HYDRA Software Utility    Electrochemical gas sensor                              Micro Medical Ltd., Kent, UK                                        19 May 2004
  ^13^CO~2~/^12^CO~2~                               *H. pylori*                          POCone Infrared Spectrophotometer                                IR spectrophotometer                                    Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan                        15 July 2004
  Alcohol                                           Breath alcohol                       AlcoMate CA2000 Digital Alcohol Detector                         Semiconductor oxide sensor                              KHN Solutions LLC, San Francisco, CA, USA                           11 August 2004
  Alcohol                                           Breath alcohol                       AlcoHAWK Precision™ Digital Alcohol Detector                     Semiconductor oxide sensor                              Q3 Innovations, LLC, Eagan, MN, USA                                 9 February 2005
  CO~2~                                             Ventilation                          C-CO2™                                                           Colorimetric carbon dioxide sensor                      Marquest Medical Products, Inc., Englewood, CO, USA                 1 March 2005
  CO~2~                                             Ventilation                          Datex-Ohmeda S/5™ Single-width airway module, E-miniC            Narrow band IR sensor                                   GE Healthcare, Needham, MA, USA                                     14 October 2005
  Alcohol                                           Breath alcohol                       AL-6000 Breath Alcohol Tester                                    Semiconductor oxide sensor                              Sentech Korea Corp., Kyeonggi-do, Korea                             11 May 2006
  Alcohol                                           Breath alcohol                       AL-5000 Breath Alcohol Tester                                    Semi-conductive alcohol sensor                          Sentech Korea Corp., Kyeonggi-do, Korea                             30 October 2006
  Alcohol                                           Breath alcohol                       Breath Alcohol .02 Detection System                              Electrochemical analyzer                                Akers Biosciences, Inc., Thorofare, NJ, USA                         18 December 2006
  CO~2~                                             Respiration                          OLG-2800A                                                        Sensor technology                                       Nihon Kohden America, Inc., Foothill Ranch, CA, USA                 27 December 2006
  Alcohol                                           Breath alcohol                       BACTRACK^®^ Breath Analyzer                                      Semiconductor oxide sensor                              KHN Solutions LLC, San Francisco, CA, USA                           14 September 2007
  CO~2~                                             Respiration, anesthesia              EMMA™ Emergency Capnometer                                       IR gas analysis                                         Phasein AB, Danderyd, Sweden                                        28 December 2007
  CO                                                CO poisoning, carboxy-haemoglobin    EC50 ToxCO+                                                      Electrochemical gas sensor technology                   Bedfont Scientific Ltd., Rochester, Kent, UK                        21 February 2008
  NO                                                Asthma, airway inflammation          NIOX MINO^®^                                                     Electrochemical sensor                                  Aerocrine AB, Solna, Sweden                                         3 March 2008
  NO                                                Asthma, airway inflammation          Apieron Insight eNO                                              Sol-gel-heme protein sensor                             Apieron, Inc., Menlo Park, CA, USA                                  14 March 2008
  Alcohol                                           Breath alcohol                       AlcoHAWK^®^ PT500 Digital Alcohol Detector                       Fuel cell sensor                                        Innovations, LLC, Independence, IA, USA                             25 July 2008
  CO~2~                                             Ventilation                          Nihon Kohden TG-970P Series CO2 Sensor Kit                       IR absorption spectrometry                              Nihon Kohden America, Inc., Foothill Ranch, CA, USA                 2 March 2009
  Alcohol                                           Breath alcohol                       BACTRACK^®^ Select Breathalyzer Model (S30, S50, S70)            Semiconductor (Si) oxide sensor                         KHN Solutions LLC, San Francisco, CA, USA                           19 March 2009
  Alcohol                                           Breath alcohol                       BACTRACK^®^ Select Breathalyzer Model S80                        Fuel cell electrochemical sensor                        KHN Solutions LLC, San Francisco, CA, USA                           24 March 2009

One recent landmark in clinical breath testing occurred in 2003 when the FDA approved the first device that measures the fraction of exhaled nitric oxide (FE~NO~) for asthma monitoring. The desktop NIOX^®^ (currently NIOX^®^ FLEX) was followed by a handheld NIOX^®^ MINO device (both by Aerocrine, Inc., Solna, Sweden) that received FDA clearance in 2008. Advantages provided by FE~NO~ monitoring devices include its non-invasive nature, ease of repeat measurements, and use in adult and child populations with severe airflow obstruction where other techniques would be difficult or impossible to perform \[[@bib-020]\]. FDA approval of these devices has largely been attributed to the standardization of clinical FE~NO~ monitoring and detection via breath analysis \[[@bib-021]\]. In order for this simple yet powerful tool to achieve its potential, we need to further understand the roles that FE~NO~ and similar biomarkers of disease play in different clinical settings and across populations, and their specific functions in disease.

A recent clinical application of breath testing has been in the diagnosis of lung cancer. Currently, clinicians rely on relatively expensive and invasive diagnostic tests, such as computed tomography exams, chest radiography, sputum analysis, and lung biopsies, which remain largely ineffective in early stage lung cancer diagnosis. Researchers have demonstrated success using trained dogs in the breath diagnosis of both early and late stage lung cancers with sensitivities and specificities approaching 99%, providing promise for future lung cancer breath tests \[[@bib-022]\]. Breath testing may provide a promising alternative diagnostic tool for lung cancer as evidenced by numerous studies with specificities and sensitivities ranging from 71-94% \[[@bib-014],[@bib-023]-[@bib-028]\]. However, in order to be useful as an upfront screening test for high-risk populations, as a tool to evaluate pulmonary nodules, or as a diagnostic test for lung cancer, a breath test should be at least 90-95% sensitive and specific \[[@bib-029]\].

As the field of breath research has developed over the past decade, the need for standardization in sampling has grown. Attempts at sampling only critical portions of exhaled breath have proven successful by using end-tidal sampling, as evidenced by finding VOC concentrations most reflective of compounds dissolved in the blood \[[@bib-030]\]. End-tidal sampling (collecting breath only at the end of exhalation) has shown success over mixed expiratory sampling (collecting the entire exhaled breath) because samples are less likely to be diluted by mixing with dead space volume (inspired air not taking place in gas exchange) and ambient air. A useful application is buffered end-tidal on-line sampling, which measures VOC breath concentrations over a large mass range quickly and uses multiple MS technologies, such as SIFT-MS and PTR-MS, for breath analysis \[[@bib-031]\]. It is also promising because it uses on-line sampling (the sampling device is connected to the analytical device) versus less accurate off-line sampling (the sample is collected and later brought to the analytical device using reservoirs such as Tedlar^®^ bags). Device calibration and validation have helped by accounting for exogenous VOCs and ambient air contamination in the sampling environment \[[@bib-019]\]. Since detection of many VOCs occurs at the parts per billion and parts per trillion levels, it is essential to control for exogenous sources of VOCs because ingestion of certain foods, medications, gut bacterial flora, and exposure to chemicals and pollution, amongst many other things, will alter VOCs in exhaled breath \[[@bib-032]\]. It is important for researchers to consider the change in the concentration of several VOCs in disease states as well as the utility of ranking systems for VOC predictability and new methods for accounting for ambient VOC sources, such as calculating alveolar gradients \[[@bib-008],[@bib-028]\]. Despite receiving considerable attention in recent years, issues with standardization have been a major limitation of clinical breath testing. This has been evidenced by difficulties in establishing baseline VOC concentrations and the wide range of results represented in the literature for VOC concentrations in disease. Thus, it is necessary in the future to search for innovative methods for breath research.

There are numerous potential advantages for breath analysis as a clinical test. The method is non-invasive (the sample is relatively easy and painless to acquire), the sample is likely to be rich with information (a single test can scan for signatures of many abnormalities or markers of disease), it has the potential for low cost, and lends itself to easy administration. The field of breath testing has grown tremendously in recent years and with evolving technologies in sampling, sensor design, standardization, and analytical methods breath analysis has the potential to clinically benefit individuals on a global scale in the future.
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